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Clinical review
How strong is the evidence of a link between
environmental chemicals and adverse effects on
human reproductive health?
Richard M Sharpe, D Stewart Irvine
Surveys show that the public suspects that synthetic
(manmade) chemicals released into the environment,
especially pesticides, have adverse effects on human
health and cause disease, including cancer. In reality,
few scientifically documented examples support this
view, especially for effects on the general population.1
However, the observation that many synthetic
chemicals have intrinsic hormonal activity—they are
“endocrine disruptors”—has reopened this debate.1
Pressure groups have called for all synthetic
environmental chemicals with the potential to cause
harm to be phased out or banned, whereas the
chemical industry argues that such action must be
based on proof of harm. Vociferous cases have been
made on both sides, each lacking definitive data. Yet it
is clear that environmental and lifestyle factors are key
determinants of human disease—accounting for
perhaps 75% of most cancers.2 New understanding
and emerging results are reshaping our thinking,
as is the recognition that establishing cause and effect
for environmental chemical exposures is a daunting
task.
Methods and scope
Though this article is primarily an overview of the cur-
rent evidence for reproductive effects resulting from
exposure to environmental synthetic chemicals, it is
relevant to the debate on wider potential health effects
of such exposures. The review was compiled after
detailed literature searches and cross referencing and
scrutiny of relevant websites on environmental chemi-
cals (see educational resources box). After revising the
article in light of reviewers’ comments, we sought the
opinion of an expert toxicologist in industry to ensure
balance in the review.
In this hugely contentious area, polarised opinions
predominate (because of the lack of definitive data).
There are enormous difficulties in establishing
whether exposure to individual chemicals or to
chemical mixtures causes harm, as adverse effects may
not manifest until many years after exposure (for
example, in adulthood after fetal exposure). This
difficulty must be factored into any discussion of this
topic.
Individuals versus populations, hazard
versus risk
Many synthetic chemicals can cause ill health or death
if individuals are highly exposed, whether
unintentionallyw1-w3 or by design—for example, from
swallowing an undiluted pesticide.3 Clearly, there is not
the same health risk to the general population, who
may be exposed to the same chemical at levels many
thousand times lower, after its release into the environ-
ment (such as by spraying on crops). Recognising that
a synthetic chemical has the potential to cause harm
reveals a “hazard.” The “risk” of this chemical actually
inducing a biological effect depends on the properties
of that chemical, but will occur only when exposure
reaches a particular level, and this can be determined
by standard toxicological methods. Risk management
is then the process of ensuring that populations and
individuals are not exposed to a risk level of the chemi-
cal in question, and this always incorporates large
(10-fold to 1000-fold) safety margins that allow for dif-
ferences in susceptibility between individuals and
between species (as toxicology testing is primarily in
animals). For pesticides, risk assessment is a highly
regulated process.
If a chemical can cause harm at very low levels of
exposure, or if levels of the chemical can build up in
the body (bioaccumulation), it may be decided that
risk cannot be safely managed, and in such instances
use of the chemical may be banned. For example, use
of persistent organochlorine chemicals, of which
DDT (dichlorodiphenyltrichloroethane) and PCBs
(polychlorinated biphenyls) are prime examples, has
been banned or restricted since the 1970s because
they bioaccumulate and cause adverse effects.1 This
decision was based primarily on adverse effects on
wildlife rather than effects on humans. Indeed, the
DDT saga was largely responsible for the introduction
of the stringent regulation and surveillance of
pesticides that occurs today. Yet despite this reassur-
ance, pesticides dominate the chemical concerns of
the public.
It would perhaps be more logical for public
concern to be focused on the enormous numbers of
References w1-w26 and extended explanations of the figures
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(non-pesticide) synthetic chemicals present in the envi-
ronment, for which toxicity or human exposure levels,
or both, are unclear.1 These chemicals (phthalates, for
example) can leach out of plastics, carpets, and fabrics
into air, rainwater, and food; are present in many
creams, soaps, and perfumes with which we adorn our
bodies; or emanate from exhaust, cigarette, and
combustion fumes.1 4 These are the synthetic chemicals
to which we are most highly exposed, yet with a few
notable exceptions, we know little about the risk they
pose to health.1 This is so even when a toxicity profile
has been established, as is the case for phthalates: argu-
ably their most important potential adverse effect—on
sexual differentiation in male fetuses5—was discovered
only four years ago. It has also become apparent in the
past two years that human exposure to phthalates is
both higher6 7 and more complexw4 than had been sup-
posed. This has prompted renewed scrutiny of
phthalates.
Endocrine disruptors and reproductive
disease or cancers
An endocrine disruptor is a chemical with the potential
to alter hormone action within the body.1 The first
endocrine disruptors identified were synthetic chemicals
that had weak intrinsic hormonal or anti-hormonal
activity, usually oestrogenic or anti-androgenic activity.1
Such compounds, when in the body, have the potential
to interact with oestrogen or androgen signalling
mechanisms (fig 1). Many ubiquitous environmental
chemicals, including organochlorine chemicals, and
numerous synthetic chemicals prevalent in developed
societies (phenolic compounds, for example) are
endocrine disruptors.1 w5 As endocrinology textbooks
show, disturbance of hormonal homeostasis can result in
clinical problems. However, it remains a topic of heated
debate as to whether the potential of endocrine disrup-
tors to disrupt hormone action and cause ill health in
humans is a reality or merely a remote, theoretical possi-
bility. What has fuelled this debate has been the increase
in incidence of two hormone dependent disorders in
humans over the past 70 or more years, namely breast
cancer8 and testicular dysgenesis syndrome (comprising
low sperm counts, testicular cancer, cryptorchidism, and
hypospadias) (fig 2).8–10
Out of this concern, epidemiological studies were
prompted, focusing on exposure to organochlorine
chemicals and breast cancer, because many organo-
chlorine chemicals are oestrogenic and, also, they are
lipophylic and can accumulate in breast fat. One initial
study produced evidence linking organochlorine
chemical exposure to increased risk of breast cancer,w6
but most subsequent studies have not confirmed this.11
These have included studies in different countries and
those that evaluated exposure to organochlorine
chemicals many years before breast cancer devel-
oped.11 Although these results are reassuring, doubts
remain about whether the most important chemicals
were measured,12 w2 whether exposure in the correct
age window was evaluated,w9 and what effect mixtures
of chemicals may have.13 Present evidence suggests that
exposure, as an adult, to organochlorine chemicals
alone is not a major determinant of breast cancer.
Indeed, it seems intuitively unlikely that endocrine dis-
ruptors with weak intrinsic oestrogenic activity1 13 can
be as important hormonal players in the aetiology of
breast cancer as the woman’s own potent endogenous
oestrogens.14
For testicular dysgenesis syndrome in males, the
aetiological involvement of endocrine disruptors is
mainly theoretical.10 Testicular dysgenesis syndrome is
thought to arise during early pregnancy. Measuring
exposure of the human fetus to chemicals and relating
this to disorders that may arise decades later (low
sperm counts, testis cancer) has major logistical
problems. However, a recent study that reported
higher levels of organochlorine chemicals in mothers
of men with testicular cancer,15 and new discoveries
about phthalates (see below), have reawakened
interest in the possible aetiological involvement of
environmental chemicals in testicular dysgenesis
syndrome.w9
“Trojan horse” environmental chemicals
Phthalates are present everywhere in our environment.
In laboratory animals, administering certain phthalates
to pregnant females induces a syndrome resembling
testicular dysgenesis syndrome in the male off-
spring.5 16 This occurs not because of any intrinsic
hormonal activity of phthalates, but because they can
suppress endogenous testosterone production by the
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Fig 1 Potential pathways of endocrine disruption by environmental
chemicals. DDE=1,1-dichloro-2, 2-bis(p-chlorophenyl)ethylene;
PAHs=polycyclic aromatic hydrocarbons; PCBs=polychlorinated
biphenyls; TBT=tributyltin
Clinical review
448 BMJ VOLUME 328 21 FEBRUARY 2004 bmj.com
fetal testis (fig 1), thus interfering with sexual differen-
tiation. Though recent reports show higher levels of
human exposure to phthalates than had been
supposed,6 7 and although women of reproductive age
are identified as a group with notably high exposure,4 6
these levels still fall considerably short of those used so
far in animal studies.
Arguably the most important lesson from the
phthalate studies has been the recognition that
environmental chemicals with the potential to alter
endogenous hormone production or metabolism may
pose a greater risk than do the many weak, receptor
mediated endocrine disruptor agents described in the
literature.1 Such biochemical endocrine disruptors
seem from screening assays based on hormone recep-
tors to be innocuous—thus they resemble the “Trojan
horse.” More and more of these agents are being iden-
tified, including common environmental chemicals.17
For example, polychlorinated biphenyls (PCBs)w10 and
certain polyhalogenated aromatic hydrocarbons
(PAHs),w11 which are products of combustion, are
potent suppressors of the enzyme oestrogen
sulphotransferase-1,17 which sulphates oestradiol
before it is excreted. Such suppression can prolong the
action of oestrogen (fig 1), a change relevant to breast
cancer.w12
New evidence for reproductive effects of
environmental chemicals
Though most concern about effects of environmental
chemicals has focussed on fetal effects (for example, in
testicular dysgenesis syndrome),10 17 w5 recent studies
point also to postnatal effects. For example, exposure
of boys to endosulfan is associated with delayed
puberty, though this could have resulted from prenatal
exposure.18 More dramatically, fertile men in an
agricultural area of Missouri have been shown to have
sperm counts about 40% lower than men in three
urban US areas,w13 and to have higher urinary concen-
trations of three currently used pesticides.19 Similarly,
direct measurement of certain phthalate metabolites is
significantly related to reduced semen quality in men,20
endometriosis in women,21 and shorter gestation
periods in pregnant women.22 Although these new
findings are suggestive, for none is the mechanism of
the chemical’s effect self evident. This leaves doubts as
to whether the measured chemicals are the real
culprits or are surrogates for other chemical exposures
or lifestyle practices.
Warnings from wildlife studies?
Despite these examples, the evidence linking human
disease and exposure to environmental chemicals
remains sketchy.1 Whether this reflects absence of
such effects or whether it reflects the immense
difficulties in demonstrating such effects, especially
where these might involve exposure to mixtures of
chemicals, remains open to debate. In the absence of
definitive data, what should guide our actions? Those
who work with wildlife species point to proof of major
effects of environmental chemicals, ranging from the
effects of DDT on birds to the more recent “feminisa-
tion” of male fish by oestrogens.1 However, the most
dramatic example, and the least well known by the
public, is the worldwide catastrophic effect of tributyl-
tin (TBT) on certain shellfish.1 Tributyltin is an
antifouling agent painted onto ships’ hulls, which then
leaches into seawater, where it masculinises female
shellfish, preventing reproduction.w14 Tributyltin is a
“Trojan horse” chemical, suppressing activity of
endogenous aromatase, thus preventing oestradiol
production (fig 1).1
As with tributyltin, many examples of the damaging
effects of environmental chemicals on wildlife involve
aquatic animals.1 Because they may be exposed continu-
ously to chemicals dissolved in the water, aquatic
animals may act as sentinels for potential effects on the
fetus, sitting as it does in an aqueous environment for
nine months. However, fetal exposure would depend on
the mother’s level of exposure (fig 3).23 Recently, fetal
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exposure to organochlorine chemicals has been
related to effects on subsequent fertility24 and
testicular cancer,15 and maternal smoking has been
related to reduced sperm counts in human offspring.25
As fetal life is increasingly recognised as a time when
susceptibility to adult disease may be induced as a
result of dietary or lifestyle effects of the mother,w15
more effects of chemical exposures seem likely to
emerge.w16-w20
Conclusion
Human exposure to environmental synthetic chemi-
cals has changed considerably in the past 70 years. This
period has witnessed major changes in our diets,
lifestyle, and social practices, some of which may be
having profound effects on human health. If environ-
mental chemicals are exerting adverse health effects in
humans, these are likely to be small in relation to those
caused by our dietary and lifestyle changes, although
these factors may interact.w21 w22 Moreover, proving that
environmental chemicals do—or do not—cause health
problems in humans against this changing back-
ground is challenging. Nowhere is this truer than in
evaluating the impact of maternal exposures in
pregnancy that may affect health of the fetus in later
life. This is unquestionably the greatest concern,1 and
we believe that alternative precautionary strategies
must be adopted, which seek to eliminate or minimise
unnecessary risks to the fetus, even in the absence of
clear proof of harm. Some of these steps can be taken
by individuals—for example, lifestyle changes in
women seeking to become pregnant (stopping
smoking, reduced use of cosmetics and body creams).
Reducing exposures by reducing release of chemicals
to the environment, however, requires action by
industry and government. The proposals by the Royal
Commission on Environmental Pollution as to how
this may be achieved (box) seem to be a practical and
effective path towards such a goal.
Contributors: The authors are both employed and paid by the
Medical Research Council (MRC) and each heads a research
team, focused on the causes of abnormal male reproductive
development and function, within the MRC Human Reproduc-
tive Sciences Unit. RMS has a longstanding interest in the area
of endocrine disruptors and is currently chairman of the UK
Society for Endocrinology Expert Group on this topic.
Key recommendations by the Royal Commission on
Environmental Pollution
• Management: Government to establish a chemicals safety coordination
unit that unites existing organisations dealing with chemicals safety
• Sorting and safety testing: All chemicals “of concern” in current use
(especially those not safety tested) to be sorted into “categories of concern”
according to hazard assessment; the most hazardous to be selected for
further investigation
• Evaluation: Chemicals found in unexpected environmental compartments
or at unexpected concentrations, or associated with unusual biological
phenomena, should be selected for further investigation
• Risk management: Where synthetic chemicals are found in raised
concentrations in biological fluids such as breast milk and in tissues of
humans, marine mammals, or top predators, regulatory steps should be
taken to remove them from the market immediately
• Funding (chemicals charge): Marketed chemicals to be levied with a tax that
is scaled according to the “category of concern.” This levy will be used to
fund the recommendations and further testing, and will provide a financial
incentive for industry to substitute chemicals “of concern” by
environmentally safer alternatives
• Legislation: New legislation to prohibit marketing of any chemical for
which basic environmental safety data is not registered
See www.rcep.org.uk/chreport.html for the full report (Chemicals in
Products—Safeguarding the Environment and Human Health)
Additional educational resources
• Regularly updated information and links on environmental chemicals
and research into their effects on wildlife species and humans:
www.EnvironmentalHealthNews.org (published daily by Environmental
Health Sciences)
http://ehp.niehs.nih.gov/who (journal of the National Institute of
Environmental Health Sciences)
http://e.hormone.tulane.edu (scientific and media information about
environmental signalling)
www.OurStolenFuture.org (regularly updated website that followed on
from a book by Theo Colborn, Dianne Dumanoski, and John Peterson
Myers)
• Exposure data for a wide range of environmental chemicals in a
representative US population is available in a recent report:
www.cdc.gov/exposurereport (Second National Report on Human
Exposure to Environmental Chemicals)
• Overview of the possible relationships between exposure to
environmental chemicals and breast cancer: www.breastcancerfund.org/
environment_evidence_main.htm
• Data on cancer incidence:
http://seer.cancer.gov (USA (Survey, Epidemiology, and End Results),
including breast and testicular cancer)
www.encr.com.fr (European data (European Network of Cancer
Registries))
www.statistics.gov.uk (UK data)
www.isdscotland.org/isd (Scottish health statistics (Information &
Statistics Division))
Summary points
Little definitive data links human reproductive
disorders or cancers with exposure to
environmental synthetic chemicals; this may
reflect difficulties in obtaining such data or the
genuine absence of effects
Synthetic chemicals are pervasive in the
environment, but understanding of their potential
to cause harm is limited
Several recent studies have shown associations
between prenatal or postnatal exposure to certain
pesticides or phthalates and reproductive
disorders in humans
Reproductive effects of environmental chemicals
in (aquatic) wildlife are well established; these may
provide sentinels for human effects, especially on
the fetus
Recent discoveries raise possibilities of effects of
common environmental chemicals on
endogenous hormones
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Lesson of the week
Bradycardia in acute haemorrhage
Ian Thomas, John Dixon
We describe three patients who all underwent elective
surgery and had acute haemorrhage after the
operation. All three patients had hypotension but did
not develop the typically associated sign of tachycardia.
The assumption that occult bleeding is always
associated with tachycardia is incorrect andmay lead to
a delay in diagnosis.
The accepted and traditional cardiovascular signs
of acute blood loss are tachycardia, hypotension, and
poor peripheral perfusion. In a healthy adult, tachycar-
dia is a heart rate of more than 100 beats/min. The
maximum heart rate a person can sustain is generally
accepted to be 220 minus the patient’s age. Tachycardia
occurs in the initial stage of a biphasic cardiovascular
response, which attempts to maintain cardiac output in
the face of hypovolaemia and a decreased stroke
volume. Neural and hormonal mechanisms mediate
this tachycardia after arterial baroreceptors are stimu-
lated. In some patients with acute haemorrhage,
however, this initial tachycardic response is absent; this
may lead to confusion or a delay in diagnosis. The phe-
nomenon has been called relative bradycardia,1–4
absence of tachycardic response,1–5 or paradoxical
bradycardia.6 We describe three patients for whom
doctors did not see initial tachycardia during acute
haemorrhage.
Case reports
Case 1
A 59 year old woman had an elective total abdominal
hysterectomy and bilateral salpingo-oophorectomy.
Apart from mild asthma, for which she took a ventolin
inhaler, she was otherwise fit and well. She was taking
no regular drugs. Her preoperative blood pressure
was 145/75 mm Hg, pulse rate was 76 beats/min, and
haemoglobin concentration was 147 g/l. Surgery was
uneventful. In the recovery room, the woman’s blood
pressure fell to 70/34, 84/42, and 78/48 mm Hg at
2.5, 4, and 5.5 hours after the operation. At each occa-
sion, doctors prescribed a fluid bolus, which increased
systolic blood pressure to greater than 100 mm Hg.
Her pulse rate never exceeded 70 beats/min (fig 1).
Six hours after the operation, her haemoglobin
concentration was 55 g/l. During laparotomy, doctors
drained 1500 ml of blood from her peritoneal cavity,
securing haemostasis. Subsequent recovery was
uneventful.
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